Jyong Biotech Ltd. (MENS)
NASDAQ: MENS · Real-Time Price · USD
2.150
+0.070 (3.37%)
At close: May 22, 2026, 4:00 PM EDT
2.050
-0.100 (-4.65%)
After-hours: May 22, 2026, 6:58 PM EDT

Jyong Biotech Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1.180.10.180.720.55
Short-Term Investments
---0.091.83
Cash & Short-Term Investments
1.180.10.180.812.39
Cash Growth
1098.98%-44.63%-78.20%-65.95%-43.51%
Other Receivables
13.51----
Total Trade Receivables
13.51----
Other Current Assets
0.860.111.661.650.26
Total Current Assets
15.540.211.842.462.65
Net Property, Plant & Equipment
3.153.193.5466.78
Other Long-Term Assets
2.082.972.870.280.01
Total Assets
20.786.378.258.759.43
Accounts Payable
00000.05
Accrued Expenses
22.931.351.180.891.06
Short-Term Debt
7.717.237.97.174.76
Current Portion of Long-Term Debt
0.570.060.080.480.18
Current Portion of Leases
0.080.160.130.170.25
Other Current Liabilities
3.523.334.974.20
Total Current Liabilities
34.8112.1314.2612.916.29
Long-Term Debt
10.1610.688.526.326.26
Long-Term Leases
0.030.020.070.120.35
Other Long-Term Liabilities
0.6920.0619.4719.0419.86
Total Long-Term Liabilities
10.8730.7628.0625.4726.46
Total Liabilities
45.6842.8942.3238.3832.76
Common Stock
00000
Treasury Stock
-16.37-16.37-16.37-16.37-16.37
Additional Paid-in Capital
28.5311.8111.8111.8111.81
Accumulated Other Comprehensive Income
0.681.120.550.590.27
Retained Earnings
-37.75-33.08-30.06-25.66-19.03
Shareholders' Equity
-24.91-36.52-34.07-29.63-23.33
Total Liabilities & Equity
20.786.378.258.759.43
Total Debt
18.5518.1416.6914.2511.79
Net Cash (Debt)
-17.37-18.04-16.51-13.44-9.4
Net Cash Per Share
-0.24-0.25-0.23-0.19-0.13
Book Value
-24.91-36.52-34.07-29.63-23.33
Book Value Per Share
-0.34-0.51-0.48-0.41-0.33
Tangible Book Value
-24.91-36.52-34.07-29.63-23.33
Tangible Book Value Per Share
-0.34-0.51-0.48-0.41-0.33
Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q